Johanna C Bendell Selected Research

Johanna C Bendell Research Topics

Disease

84	Neoplasms (Cancer) 04/2022 - 06/2003
37	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 02/2006
14	Fatigue 03/2022 - 01/2013
12	Disease Progression 01/2021 - 11/2011
12	Adenocarcinoma 10/2020 - 03/2007
11	Nausea 03/2022 - 01/2013
8	Diarrhea 01/2022 - 12/2013
8	Neutropenia 01/2021 - 09/2012
7	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2003
7	Thrombocytopenia (Thrombopenia) 01/2019 - 07/2012
7	Rectal Neoplasms (Rectal Cancer) 09/2017 - 02/2006
6	Exanthema (Rash) 03/2022 - 02/2011
6	Vomiting 01/2020 - 04/2013
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 05/2007
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2016
5	Anemia 01/2022 - 01/2014
5	Carcinoma (Carcinomatosis) 04/2013 - 05/2005
4	Hypertension (High Blood Pressure) 01/2021 - 07/2017
4	Edema (Dropsy) 01/2020 - 01/2014
4	Mucositis 02/2015 - 02/2011
4	Esophageal Neoplasms (Esophageal Cancer) 07/2012 - 03/2007
3	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 03/2016
3	Wounds and Injuries (Trauma) 01/2019 - 06/2013
3	Asthenia 01/2019 - 01/2013
3	Febrile Neutropenia 08/2013 - 03/2008
3	Pathologic Complete Response 03/2008 - 03/2007
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2019
2	Brain Neoplasms (Brain Tumor) 01/2022 - 06/2003
2	Stomach Neoplasms (Stomach Cancer) 11/2021 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 10/2021 - 01/2021
2	Anorexia 01/2020 - 03/2016
2	Stomatitis 01/2019 - 01/2015
2	Melanoma (Melanoma, Malignant) 12/2015 - 08/2012
2	Inflammation (Inflammations) 12/2015 - 04/2003
2	Uveitis 02/2015 - 06/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2008 - 03/2007
2	Anus Neoplasms (Anal Cancer) 05/2007 - 04/2003

Drug/Important Bio-Agent (IBA)

29	Bevacizumab (Avastin)FDA Link 04/2022 - 06/2007
15	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 06/2007
13	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 04/2003
11	Irinotecan (Camptosar)FDA LinkGeneric 07/2016 - 08/2007
11	Capecitabine (Xeloda)FDA Link 12/2015 - 02/2006
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 06/2013
9	Cetuximab (Erbitux)FDA Link 01/2021 - 08/2007
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 06/2007
6	Everolimus FDA Link 01/2022 - 01/2011
6	Panitumumab (Vectibix)FDA Link 01/2021 - 01/2011
6	Gemcitabine FDA Link 01/2019 - 01/2011
5	trifluridine tipiracil drug combinationIBA 01/2021 - 11/2015
5	Monoclonal AntibodiesIBA 01/2020 - 04/2013
5	Pharmaceutical PreparationsIBA 01/2020 - 08/2007
5	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 03/2007
5	Paclitaxel (Taxol)FDA LinkGeneric 09/2012 - 03/2007
4	Phosphotransferases (Kinase)IBA 01/2022 - 10/2015
4	Leucovorin (Folinic Acid)FDA Link 01/2021 - 03/2008
4	trametinibIBA 01/2020 - 08/2012
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 08/2012
3	Circulating Tumor DNAIBA 04/2022 - 01/2020
3	NivolumabIBA 03/2022 - 01/2021
3	Transaminases (Aminotransferases)IBA 01/2022 - 06/2013
3	pembrolizumabIBA 11/2021 - 01/2020
3	prexasertibIBA 01/2021 - 01/2020
3	dabrafenibIBA 01/2020 - 12/2015
3	Biological ProductsIBA 01/2020 - 09/2013
3	130-nm albumin-bound paclitaxelIBA 01/2019 - 12/2017
3	Messenger RNA (mRNA)IBA 12/2017 - 01/2013
3	ErbB Receptors (EGF Receptor)IBA 03/2016 - 02/2006
2	SteamIBA 04/2022 - 01/2020
2	LY3023414IBA 01/2022 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2021 - 10/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 11/2007
2	Pemetrexed (MTA)FDA Link 01/2021 - 08/2013
2	atezolizumabIBA 11/2020 - 01/2016
2	RamucirumabIBA 10/2020 - 01/2019
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 06/2003
2	Differentiation AntigensIBA 01/2020 - 08/2014
2	regorafenibIBA 01/2019 - 10/2015
2	ME-344IBA 10/2017 - 04/2015
2	Axitinib (AG 013736)IBA 07/2017 - 12/2013
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017 - 09/2013
2	onartuzumabIBA 01/2017 - 09/2013
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 07/2016 - 01/2015
2	AntigensIBA 01/2016 - 01/2009
2	TOR Serine-Threonine KinasesIBA 01/2016 - 10/2015
2	KRN-330IBA 08/2014 - 04/2013
2	NVP-BKM120IBA 08/2014 - 01/2012
2	Angiogenesis InhibitorsIBA 08/2013 - 08/2007
2	PanobinostatIBA 09/2012 - 03/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2012 - 02/2011
2	Dihydrotachysterol (AT 10)IBA 07/2012 - 09/2011
1	Androgen Receptors (Androgen Receptor)IBA 01/2022

Therapy/Procedure

33	Therapeutics 03/2022 - 06/2003
28	Drug Therapy (Chemotherapy) 01/2021 - 04/2003
14	Radiotherapy 01/2019 - 04/2003
5	Neoadjuvant Therapy 10/2017 - 08/2007
3	Chemoradiotherapy 01/2009 - 11/2007
2	Castration 01/2022 - 01/2019
2	Adjuvant Chemotherapy 01/2021 - 06/2007
2	Esophagectomy 03/2008 - 03/2007
2	Proctectomy 05/2007 - 04/2003